Northern Trust Corp Biomarin Pharmaceutical Inc Transaction History

Northern Trust Corp

  • $658 Billion
  • Q1 2025

A detailed history of Northern Trust Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,696,864 shares of BMRN stock, worth $92.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,696,864
Previous 1,725,039 1.63%
Holding current value
$92.8 Million
Previous $113 Million 5.79%
% of portfolio
0.02%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$61.25 - $72.83 $1.73 Million - $2.05 Million
-28,175 Reduced 1.63%
1,696,864 $120 Million
Q4 2024

Feb 14, 2025
BUY
$61.93 - $70.49 $14.9 Million - $17 Million
240,681 Added 16.21%
1,725,039 $113 Million
Q3 2024

Nov 13, 2024
SELL
$69.02 - $93.84 $6.48 Million - $8.81 Million
-93,901 Reduced 5.95%
1,484,358 $104 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $37.2 Million - $46.1 Million
500,230 Added 46.4%
1,578,259 $130 Million
Q1 2024

May 14, 2024
SELL
$83.81 - $99.0 $6.1 Million - $7.2 Million
-72,754 Reduced 6.32%
1,078,029 $94.2 Million
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $5.26 Million - $6.8 Million
-69,031 Reduced 5.66%
1,150,783 $111 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $3.72 Million - $4.13 Million
43,695 Added 3.72%
1,219,814 $108 Million
Q2 2023

Aug 11, 2023
SELL
$86.68 - $100.3 $11.2 Million - $13 Million
-129,319 Reduced 9.91%
1,176,119 $102 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $21,759 - $29,082
248 Added 0.02%
1,305,438 $127 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $945,505 - $1.27 Million
11,683 Added 0.9%
1,305,190 $135 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $905,403 - $1.07 Million
-11,020 Reduced 0.84%
1,293,507 $110 Million
Q2 2022

Aug 12, 2022
SELL
$71.48 - $86.85 $1.57 Million - $1.9 Million
-21,927 Reduced 1.65%
1,304,527 $108 Million
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $2.75 Million - $3.43 Million
-37,047 Reduced 2.72%
1,326,454 $102 Million
Q4 2021

Feb 08, 2022
BUY
$71.72 - $91.47 $587,243 - $748,956
8,188 Added 0.6%
1,363,501 $120 Million
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $5.3 Million - $6.06 Million
70,868 Added 5.52%
1,355,313 $105 Million
Q2 2021

Aug 13, 2021
BUY
$75.51 - $84.79 $5.24 Million - $5.89 Million
69,449 Added 5.72%
1,284,445 $107 Million
Q1 2021

May 12, 2021
BUY
$74.73 - $90.69 $2.27 Million - $2.76 Million
30,432 Added 2.57%
1,214,996 $91.7 Million
Q4 2020

Feb 11, 2021
SELL
$72.61 - $90.2 $2.64 Million - $3.28 Million
-36,355 Reduced 2.98%
1,184,564 $104 Million
Q3 2020

Nov 16, 2020
SELL
$71.87 - $131.03 $5.31 Million - $9.68 Million
-73,890 Reduced 5.71%
1,220,919 $92.9 Million
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $5.78 Million - $9.02 Million
72,606 Added 5.94%
1,294,809 $160 Million
Q1 2020

May 14, 2020
BUY
$71.37 - $96.85 $5.95 Million - $8.07 Million
83,344 Added 7.32%
1,222,203 $103 Million
Q4 2019

Feb 14, 2020
SELL
$64.27 - $86.37 $3.43 Million - $4.61 Million
-53,379 Reduced 4.48%
1,138,859 $96.3 Million
Q3 2019

Nov 13, 2019
SELL
$67.4 - $85.11 $1.62 Million - $2.04 Million
-24,025 Reduced 1.98%
1,192,238 $80.4 Million
Q2 2019

Aug 13, 2019
BUY
$80.35 - $93.9 $1.12 Million - $1.31 Million
13,949 Added 1.16%
1,216,263 $104 Million
Q1 2019

May 13, 2019
BUY
$84.2 - $98.62 $1.69 Million - $1.98 Million
20,108 Added 1.7%
1,202,314 $107 Million
Q4 2018

Feb 12, 2019
BUY
$80.14 - $106.07 $6.05 Million - $8.01 Million
75,550 Added 6.83%
1,182,206 $101 Million
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $226,065 - $254,468
-2,407 Reduced 0.22%
1,106,656 $107 Million
Q2 2018

Sep 18, 2018
SELL
$76.01 - $99.03 $856,708 - $1.12 Million
-11,271 Reduced 1.01%
1,109,063 $104 Million
Q2 2018

Aug 14, 2018
BUY
$76.01 - $99.03 $1.79 Million - $2.34 Million
23,597 Added 2.15%
1,120,334 $106 Million
Q1 2018

May 09, 2018
SELL
$77.67 - $92.63 $1.03 Million - $1.23 Million
-13,295 Reduced 1.2%
1,096,737 $88.9 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $480,683 - $566,213
5,952 Added 0.54%
1,110,032 $99 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $89 Million - $105 Million
1,104,080
1,104,080 $103 Million

Others Institutions Holding BMRN

# of Institutions
668
Shares Held
184M
Call Options Held
1.24M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email